Appeals court blocks launch of generic Aciphex

07/22/2008 | Bloomberg1

The U.S. Court of Appeals for the Federal Circuit rejected an appeal from Dr. Reddy's Laboratories and Teva Pharmaceutical Industries that challenged Eisai's patent for Aciphex, a treatment for stomach ulcer. The decision prohibits the generic-drug firms from making their versions until the patent expires in May 2013.

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC